A. Struthers

发表

Cardiovascular consequences of laparoscopic surgery

A. Cuschieri, A. Struthers, 1998, The Lancet.

British Journal of Clinical Pharmacology

B. Lipworth, P. Waller, G. Tucker, 2013 .

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths

A. Morris, A. Struthers, A. Morris, 2002, The Lancet.

Influence of candoxatril on plasma brain natriuretic peptide in heart failure

W. Coutie, A. Struthers, J. Motwani, 1991, The Lancet.

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

P. Poole‐Wilson, D. Wood, A. Coats, 1997, The Lancet.

Shifts in mortality curves

A. Struthers, P. Lim, 1999, The Lancet.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Screening for and treatment of left-ventricular abnormalities in diabetes mellitus

A. Morris, A. Struthers, 2002, The Lancet.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion.

H. Elliott, A. Struthers, G. Addis, 1982, British medical journal.

Optimization of the contrast dose and injection rates in whole‐body MR angiography at 3.0T

S. Waugh, J. Belch, S. Gandy, 2009, Journal of magnetic resonance imaging : JMRI.

Annual Scientific Meeting of ASCEPT, 1999 Careful Screening To Target Interventions To Prevent Sudden Cardiac Death

A. Struthers, A. Struthers, 2001 .

QT dispersion and triplevessel coronary disease

S. Pringle, T. Pringle, N. Davidson, 1997, The Lancet.

Social deprivation increases cardiac hospitalisations in chronic heart failure independent of disease severity and diuretic non-adherence

P. Donnan, T. MacDonald, A. Struthers, 2000, Heart.

Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma

B. Lipworth, T. Moreland, A. Struthers, 1989, European Journal of Clinical Pharmacology.

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

P. Donnan, T. MacDonald, A. Struthers, 2002, Heart.

B-type natriuretic peptide: a simple new test to identify coronary artery disease?

A. Struthers, J. Davies, A. Struthers, 2005, QJM : monthly journal of the Association of Physicians.

Lisinopril improves arterial function in hyperlipidaemia.

A. Struthers, J. Dick, A. Struthers, 1999, Clinical science.

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction

A. Struthers, N. Kennedy, A. Struthers, 1993, The Lancet.

Can drug effects on mortality in heart failure be predicted by any surrogate measure?

K. Yee, A. Struthers, A. Struthers, 1997, European heart journal.

Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

C. Lang, A. Struthers, A. Choy, 1992, Clinical science.

Lisinopril improves arterial function in hyperlipidaemia.

J. Dick, A. Struthers, Alison F.C. Lee, 1999, Clinical science.

Aldosterone blunts the baroreflex response in man.

K. Yee, A. Struthers, A. Struthers, 1998, Clinical science.

Association between allopurinol and mortality in heart failure patients: a long‐term follow‐up study

T. Fahey, T. MacDonald, A. Struthers, 2009, International journal of clinical practice.